New Chromabond® Drug Ii

Chromatography

New Chromabond® Drug Ii

15 May, 2007

Published over 19 years ago. See the latest and most current information on Chromatography.

Macherey Nagel GmbH introduces a specific cartridge for solid phase extraction for enrichment of THC (tetrahydrocannabinol) and THC-derivates from blood or urine. The determination of tetrahydrocannabinol and its metabolites is an important procedure in analysis of drugs of abuse and is offered as standard routine method by many laboratories. After enrichment of the analytes respectively pre-cleaning of the sample by SPE subsequent identification by GC/MS is proceeded.

CHROMABOND® Drug II contains a bifunctional adsorbent material, consisting from a strong anion exchanger (SAX, quaternary amine) and C8 modified silica. Two primary retention mechanisms facilitate the use of very strong interferant eluting solvents resulting in very pure extracts especially from heavily matrix loaded samples like urine, plasma, serum or whole blood.

Already available from Macaherey Nagel is CHROMABOND® Drug a SPE-cartridge for enrichment of acidic, neutral and basic drugs. By introducing CHROMABOND® Drug II the scope of SPE products for drug analysis is widened by the important group of THCs.

Latest News

ILM 51.6 Sept 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Independent studies strengthen the evidence for quantitative optical gas imaging
Explore more Arrow
Pollution Solutions Online
Safe drinking water worldwide
Explore more Arrow
Petro Online
Independent studies strengthen the evidence for quantitative optical gas imaging
Explore more Arrow
Chromatography Today
Inline degasser range upgraded with new vacuum control and pump technology
Explore more Arrow